Find Academic Supervisors

Joshua J. SolanoView profile

Associate Professor

• Emergency Medicine
• Geriatric Emergency Care
• Medical Education
• +4 more

Joshua J. Solano, M.D., FAAEM is an Associate Professor of Emergency Medicine and Clerkship Director for the Emergency Medicine Residency program at the Florida Atlantic University Charles E. Schmidt College of Medicine. As Clerkship Director, he works alongside residents to promote best practices for emergency department patient care. Dr. Solano is board certified in emergency medicine and maintains active membership in the American College of Emergency Physicians and the American Academy of Emergency Medicine. Dr. Solano's educational background includes a BS in Biology and BA in History from Duke University, followed by his MD from the University of Florida. He completed his emergency medicine residency at Beth Israel Deaconess Medical Center in Boston and served on faculty at Harvard Medical School as an instructor and assistant program director before joining FAU. In his final year in Boston, he completed the Rabkin Medical Education Fellowship. Dr. Solano's research focuses on geriatric emergency medicine, particularly head trauma management in elderly patients, anticoagulation risks, and emergency department quality assurance. His recent publications demonstrate a strong emphasis on developing clinical decision rules for geriatric head trauma and understanding medication interactions in older emergency patients. He has also contributed significantly to medical education literature, developing innovative residency training curricula. His scholarly work shows a clear progression toward establishing evidence-based guidelines for geriatric emergency care, with numerous publications on intracranial hemorrhage risk assessment, anticoagulation management, and fall prevention strategies. Dr. Solano's research bridges clinical practice with educational innovation, making significant contributions to both patient care protocols and emergency medicine training. 2017: Attending Role Model Award, Beth Israel Deaconess Medical Center 2016-2017: Rabkin Medical Education Fellowship 2011: Alpha Omega Alpha Medical Honor Society 2011: Chapman Humanism Society 2010: Equal Access Clinic Service Award 2010: Lawrence M. Goodman Award for Medical Student Research 2010: Community Service Award As Clerkship Director, Dr. Solano oversees medical student education in emergency medicine and has implemented electronic evaluation systems that have increased the quality and quantity of student assessments. His clinical work includes staff positions at Bethesda East Hospital and Delray Medical Center. Dr. Solano's research program demonstrates strong institutional support through multiple publications and ongoing investigations into geriatric emergency care protocols.

• Pharmacotherapy outcomes
• Critical care
• Trauma
• +2 more

Jeffrey F. Barletta is a Professor with tenure and Vice Chair of Pharmacy Practice at Midwestern University College of Pharmacy - Glendale Campus. With over 25 years of experience as a critical care clinician, Dr. Barletta maintains an active clinical practice at HonorHealth John C. Lincoln Medical Center in Phoenix, AZ, where he serves as a member of the trauma/surgical ICU team. His academic career includes previous positions as a clinical specialist in surgical critical care at Spectrum Health in Grand Rapids, MI and Detroit Receiving Hospital in Detroit, MI. Dr. Barletta's educational background includes: Pharm.D. from Temple University, USA (1996) B.S. from Philadelphia College of Pharmacy & Science, USA (1995) Residency in Pharmacy Practice at University of Arizona, Tucson Residency in Critical Care at University of Arizona, Tucson Dr. Barletta's research focuses on pharmacotherapy outcomes in critically ill patients , with particular emphasis on critical care and trauma. His work examines medication safety and effectiveness in high-acuity settings, especially regarding stress ulcer prophylaxis, electrolyte management, and pharmacotherapy for critically ill trauma patients. He has contributed significantly to guidelines development in critical care pharmacotherapy, particularly for stress-related gastrointestinal bleeding prevention and heat stroke management. His research bridges clinical practice and evidence-based medicine to optimize drug therapy in the ICU setting. Analysis of Dr. Barletta's recent publications reveals a strong focus on critical care pharmacotherapy, particularly stress ulcer prophylaxis, gastrointestinal bleeding prevention, and management of electrolyte disorders in critically ill patients. His work frequently appears in high-impact critical care journals and often involves multicenter collaborations. A notable trend is his leadership in developing clinical practice guidelines through professional societies like the Society of Critical Care Medicine. Dr. Barletta has received significant recognition for his contributions to the field: Fellow of the American College of Critical Care Medicine (FCCM) Fellow of the American College of Clinical Pharmacy (FCCP) As an academic leader, Dr. Barletta serves on the Council for the Society of Critical Care Medicine and has held leadership positions including past-Chair of the Clinical Pharmacy and Pharmacology Section of SCCM and past Editor of Critical Connections. He was also a past member of the American Board of Internal Medicine, Critical Care Specialty Board and an inaugural member of the Executive Committee for the Critical Care Pharmacotherapy Trials Network. His teaching activities include courses in Acute Care Management and Acute Care Patient Management. Dr. Barletta has authored more than 130 peer-reviewed manuscripts and textbook chapters and served as co-editor of "Drug-Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment." His work demonstrates a sustained commitment to advancing critical care pharmacy practice through research, education, and professional leadership.

Mark FitzgeraldView profile

Adjunct Professor

• Trauma Systems Improvement
• Resuscitation Care Standardization
• Trauma Error Reduction
• +3 more

Professor Mark Fitzgerald is a leading academic and clinician in trauma care, holding dual roles as Director of Trauma Services at The Alfred Hospital and Director of the National Trauma Research Institute. He is also an Adjunct Professor at Monash University’s Department of Surgery and Honorary Professor at Deakin University’s School of Information Technology. His work focuses on trauma systems improvement, reducing errors in resuscitation care, and standardizing life-saving protocols. Education: MBBS (University of Melbourne, 1981) Fellowship Australasian College for Emergency Medicine (1987) MD (Monash University, 2015) on Computer-Assisted Decision Support for Trauma Resuscitation Global Clinical Scholar in Epidemiology and Biostatistics (Harvard Medical School, 2015) Grad. Cert. Internet Communications (Curtin University, 2019) Research Interests: Professor Fitzgerald’s research emphasizes trauma system development globally (e.g., China, India, Saudi Arabia), error reduction in critical care, and innovative resuscitation techniques. His work aligns with UN Sustainable Development Goals, particularly targeting reductions in preventable deaths and improved healthcare access. Awards: Ambulance Service Medal (2003) Foundation Medal, Australasian College for Emergency Medicine (2003) Honorary Life Membership, Neurotrauma Society of India (2010) Gordon Trinca Medal for Trauma Services (2013) Grants & Funding: Secured over AUD$10m in research grants and AUD$16m in development funding for trauma initiatives. Active in multicenter trials, including the Advancing Care Through Injury Outcome Navigators (ACTION) Study and trials evaluating novel hemorrhage-control agents like BE1116. Labs & Teams: Leads the Trauma Reception & Resuscitation Project and collaborates internationally on trauma system optimization. His team develops digital tools for decision support and error mitigation in emergency settings.

• Organic Chemistry
• Bioactive Peptides
• Antimicrobial Development
• +7 more

Eduard Bardají Rodríguez is a Professor in the Department of Chemistry at the University of Girona, where he has been active since 1992. He is affiliated with the Institute of Agro-Food Technology and leads the LIPPSO research group (Laboratory for Innovation in Organic Synthesis Processes and Products), recognized as a Consolidated Research Group by the Generalitat de Catalunya. His work bridges organic chemistry, biomedicine, and agro-food innovation through the design and application of bioactive peptides. Research Interests: His primary focus lies in the discovery and development of bioactive peptides with applications in antimicrobial, anticancer, analgesic, neuroprotective, and cardiovascular therapies. His work integrates synthetic organic chemistry with biological evaluation, aiming to translate basic findings into practical solutions in medicine and agriculture. The recent publication trends highlight a strong emphasis on peptide-based drug discovery, particularly targeting pain, neurodegeneration, and infectious diseases. His research extends into plant biotechnology (e.g., expressing antimicrobial peptides in rice) and combating citrus diseases (HLB), demonstrating a multidisciplinary approach spanning human health and sustainable agriculture. Scientific Awards and Recognition: Consolidated Research Group status for LIPPSO by the Generalitat de Catalunya Advising and Grants: He has led and participated in numerous competitive research projects, including MINECO, PLANT-KBBE (Trilateral Project), IAPP PEP2BRAIN, and H2020 PreHLB. He has established industrial collaborations with companies such as Medichem, Croda, and Menadione. He co-founded the spin-off AMPbiotech to commercialize antimicrobial technologies, reflecting a strong commitment to technology transfer and innovation. Laboratories and Teams: He leads the LIPPSO research group and maintains a strategic alliance with the CIDSAV group, fostering collaborative research in applied antimicrobial development.

Paula HammondView profile

Professor

• Nanotechnology
• Chemical Engineering
• Drug Delivery
• +12 more

Paula T. Hammond is the David H. Koch Professor of Engineering, head of the Department of Chemical Engineering, and a member of the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. A pioneer in nanotechnology and polymer science, she develops layer-by-layer (LbL) nanoparticle platforms for cancer therapy, wound healing, vaccine delivery, and synthetic blood substitutes. Her work bridges chemical engineering, materials science, and biomedical applications with a focus on translational research. BS in Chemical Engineering, MIT (1984) MS in Chemical Engineering, Georgia Tech (1988) PhD in Chemical Engineering, MIT (1993) Research Interests : Hammond’s research spans nano-based drug delivery , immunotherapy , biomedical implants , and self-assembling materials . Her lab designs LbL nanoparticles for ovarian cancer , glioblastoma , and intractable cancers , enabling combination therapies (siRNA, proteins, chemotherapy). Recent work includes ML-driven nanoparticle design and two-component hemostatic systems for internal bleeding. Article Trends : Her recent publications (2025) emphasize modular LbL nanoparticles for hematopoietic stem cells , cancer immunostimulation , and multi-drug delivery . Broader keywords include Nanotechnology , Biomaterials , RNA Therapeutics , while sub-fields cover targeted drug release , immune activation , and synthetic oxygen transport . Scientific Awards : National Medal of Technology and Innovation (2024) Othmer Gold Medal (2024) Benjamin Franklin Medal in Chemistry (2024) James R. Killian Faculty Achievement Award (2023-24) MIT Institute Professor (2021) Three-time National Academy member (Sciences, Engineering, Medicine) Advising & Leadership : Hammond has mentored over 60 graduate students and postdocs , co-founded LayerBio, Inc. , and serves on scientific advisory boards for Moderna and Burroughs-Wellcome Fund . She chairs MIT’s Initiative on Faculty Race and Diversity and contributes to national science policy through PCAST. Lab & Collaborations : The Hammond Lab at MIT’s Koch Institute develops LbL nanoparticle systems with applications in cancer, regenerative medicine, and hemostasis. Collaborations include the MIT Institute for Soldier Nanotechnology and partnerships with clinicians, biologists, and engineers.

• Magnetic Resonance Imaging
• Diffusion Neuroscience
• Functional Magnetic Resonance
• +5 more

Professor Martin Koch is a distinguished academic at the Institute of Medical Engineering at the University of Lübeck, where he serves as Head of Magnetic Resonance Imaging. Born in Dinslaken, Germany in 1968, he completed his physics education at Göttingen University, including studies at the University of Edinburgh, followed by a PhD at the University of Leipzig. After over a decade as a Research Associate at University Medical Center Hamburg-Eppendorf, he joined the University of Lübeck in 2011 as a Juniorprofessor of Magnetic Resonance Imaging, achieving full professorship in November 2018. His research focuses on advanced MRI techniques, particularly diffusion imaging methods that reveal microscopic neural structures. Koch has made significant contributions to double wave vector diffusion weighting techniques for compartment size estimation in tissue, with applications in neuroscience and clinical diagnostics. His work spans Magnetic Resonance Imaging, Diffusion Neuroscience, Functional Magnetic Resonance, Biochemical Engineering, Magnetic Particle Imaging, Nuclear Imaging, Image Computing, and X-Ray Based Imaging. Over the past two decades, his publications demonstrate consistent innovation in developing and validating advanced diffusion MRI techniques, with recent work expanding into magnetic particle imaging applications. Analysis of his 15 most recent publications reveals a strong focus on technical innovations in diffusion MRI for neural tissue characterization, with increasing applications in interventional imaging and real-time monitoring. His research shows progression from fundamental diffusion physics to clinical applications, particularly in neurological conditions and cardiovascular imaging. Professor Koch actively participates in academic governance as a Member of Promotionskolleg Schleswig-Holstein and the Zentraler Gleichstellungsausschuss. His laboratory focuses on developing novel imaging techniques that provide microscopic insights into tissue structure, with particular relevance to neurological disorders and stroke recovery monitoring.

• Cancer Biology
• Oncology
• Molecular Biology
• +3 more

Weei-Chin Lin is a Professor at Baylor College of Medicine , affiliated with the Department of Medicine and cross-appointed to the Department of Molecular & Cellular Biology and Duncan Cancer Center . His research focuses on Cancer Biology , Molecular Biology , and Biochemistry , particularly mechanisms of DNA damage response, oncogenic pathways, and therapeutic targeting. Selected publications highlight work on TopBP1 in cancer, PARP inhibitors , EGFR regulation , and 14-3-3 proteins . Key themes include synthetic lethality , checkpoint control , ubiquitination , and metastasis mechanisms . Scientific awards include NIH grants, NIH BCO Study Section member (2025-2029) Cancer Center pilot awards Leukemia & Lymphoma Society Scholar (2006-2011) His work bridges translational oncology and molecular mechanisms , with clinical implications for chemotherapy resistance and novel cancer therapies .

• Radiology
• Abdominal Imaging
• CT Colonography
• +5 more

Joseph T Ferrucci is a distinguished Professor of Radiology at UMass Chan Medical School's T.H. Chan School of Medicine, specializing in Abdominal Imaging within the Department of Radiology. With over four decades of academic and clinical experience, Dr. Ferrucci has established himself as a leading authority in gastrointestinal radiology, particularly in CT colonography and virtual colonoscopy techniques. His educational foundation includes an AB in Liberal Arts from Harvard University, an MD from Tufts University School of Medicine, Radiology Residency at Massachusetts General Hospital, and a Teaching Fellowship in Radiology at Harvard Medical School. This rigorous training provided the foundation for his subsequent contributions to abdominal imaging and interventional radiology. Dr. Ferrucci's research interests focus on advancing gastrointestinal imaging techniques, with particular emphasis on CT colonography, virtual colonoscopy, and interventional approaches to abdominal conditions. His work has significantly influenced clinical practice guidelines for colorectal cancer screening and the standardization of CT colonography reporting. Analysis of his publication history reveals consistent scholarly output with particular concentration on virtual colonoscopy development between 1998-2006, where he contributed to establishing both technical standards and clinical applications of this important screening modality. His most impactful publications include the highly cited 2003 colorectal cancer screening guidelines (611 citations) and the 2005 CT colonography reporting standards consensus (156 citations), demonstrating his leadership in shaping clinical practice in gastrointestinal radiology. Dr. Ferrucci's work spans both technical innovations in imaging methodology and practical clinical applications, with particular strength in translating research findings into clinical practice. Throughout his career, Dr. Ferrucci has maintained active involvement in both the academic and clinical aspects of radiology, contributing to the education of future radiologists while advancing the field through his research. His collaborative approach is evident in the numerous multi-institutional studies he has participated in, particularly in establishing consensus guidelines for colorectal cancer screening and CT colonography implementation.

Scott B. ArmenView profile

Professor

• Trauma Surgery
• Surgical Critical Care
• Thoracic and Vascular Trauma
• +7 more

Scott B. Armen, MD is the Charlene J. Smith Professor of Surgery and Neurosurgery, Vice-Chair of the Department of Surgery for Patient Safety and Quality, and Chief of the Division of Trauma, Acute Care and Critical Care Surgery at Penn State College of Medicine. He also serves as the Adult Level 1 Trauma Program Medical Director and Surgical Director of Quality and Patient Safety for Penn State Health Milton S. Hershey Medical Center. Dr. Armen's research focuses on trauma surgery, surgical critical care, and combat casualty care. His specific interests include thoracic and vascular trauma, shock resuscitation, sepsis, combat casualty care, and surgical quality improvement. His work spans both civilian and military trauma settings, with significant contributions to geriatric trauma, traumatic brain injury, and hemorrhage control. His recent publications (2024-2025) demonstrate continued focus on geriatric trauma outcomes, military-civilian trauma system integration, blood product utilization in trauma, and combat casualty care. These works reflect his dual expertise in academic trauma surgery and military medicine. Dr. Armen has received significant recognition including: US Army Combat Action Badge (2019) Fellow of the American College of Surgeons Fellow of the American College of Chest Physicians Fellow of the American College of Critical Care Medicine Charlene J. Smith Professor (Endowed Chair) As a Colonel in the US Army Reserve, Dr. Armen serves as the US Army Reserve General Surgery Consultant to The Army Surgeon General and Chief Surgeon of the 629th Forward Resuscitative Surgical Detachment. His five combat deployments include service in Syria, Afghanistan (twice), and Iraq (twice), where he served in various surgical leadership roles.

• Child Psychiatry
• Autism Spectrum Disorder
• Attention-Deficit/Hyperactivity Disorder
• +4 more

James McCracken is a tenured Professor of Psychiatry and Biobehavioral Sciences at UCLA's David Geffen School of Medicine. As Director of the Division of Child and Adolescent Psychiatry at the Semel Institute for Neuroscience and Human Behavior, he leads the NIMH-funded Research Center 'Translational Research to Enhance Cognitive Control' focusing on novel treatments for cognitive deficits in child psychiatry. His research spans pharmacogenomics, neurodevelopmental disorders (ASD, ADHD, OCD), and autonomic neurophysiology. Key affiliations: Center for Autism Research and Treatment (CART), ADHD Brain Research Institute, Society for Neuroscience Research themes: Pharmacologic interventions for neurodevelopmental disorders, white matter sex differences, EEG biomarkers, and genome-wide association studies Leadership roles: Principal Investigator for multiple NIMH grants, editorial board member for the Journal of Child and Adolescent Psychopharmacology His recent publications (2023-2025) emphasize precision medicine in ASD, OCD genetics, and pupillary response as a neurophysiological marker. Awards include the APA Young Psychiatrist Research Award and listings in Best Doctors and Top Doctors databases. Scientific Awards American Psychiatric Association Young Psychiatrist Research Award Best Doctors in America America's Top Doctors Publications Over 150 peer-reviewed articles across child psychiatry Leading research in pharmacogenomics and neuroimaging

• Contraception
• Reproductive Health
• Women's Mental Health
• +6 more

Dustin James Costescu is an Associate Professor in the Department of Obstetrics & Gynecology at McMaster University's Faculty of Health Sciences. His research focuses on contraception access and education hormonal impacts on mental health HPV testing for cervical cancer screening maternal health disparities . Recent publications highlight his work in hormonal contraception efficacy , abortion medication availability , and intrauterine device design . His studies often bridge clinical practice with health policy, particularly in underserved populations like incarcerated women. Key collaborations include health technology assessments and clinical guidelines development, with significant engagement in Canadian policy frameworks and medical education innovation .

• Applied statistics
• Clinical cancer research
• Controlled clinical trials
• +5 more

Eva Skovlund is a Professor at the Department of Public Health and Nursing , Norwegian University of Science and Technology (NTNU), Faculty of Medicine and Health Sciences. Her work bridges applied statistics with clinical research in cancer, obesity, and chronic disease management. Education : PhD in Medical Statistics, University of Oslo (1990) MSc in Pharmacy, University of Oslo (1985) Research Interests : Eva focuses on applied statistical methods , clinical cancer research , controlled clinical trials , and drug safety assessment . Her work spans hypertension management in Nepal, neuro-oncology, and metabolic effects of bariatric surgery. Publication Trends : Recent articles (2021–2025) emphasize brain metastases prognosis hypertension interventions in South Asia pharmacokinetic studies in obesity statistical modeling for multimorbidity maternal and child health risks Scientific Contributions : While no specific awards are listed, her extensive peer-reviewed publications in Cancers , BMJ Open , Clinical Pharmacokinetics , and Tidsskriftet underscore her impact.

Saurav ChopraView profile

Assistant Professor

• Hematopathology
• Clinical Pathology
• Myeloid Neoplasms
• +5 more

Saurav Chopra, MBBS, serves as an Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Kansas Medical Center's School of Medicine. His professional journey began with an MBBS from the All India Institute of Medical Sciences in New Delhi, India, followed by residency training in anatomic and clinical pathology at the University of Iowa Carver College of Medicine, and a hematopathology fellowship at the University of Pittsburgh Medical Center. Dr. Chopra's research spans several critical areas in hematology and pathology, with particular focus on hematopathology diagnostics, myeloid neoplasms classification, and hematologic parameters in viral infections including SARS-CoV-2. His work demonstrates expertise in advanced diagnostic techniques such as flow cytometry and fluorescence in situ hybridization for monitoring hematologic malignancies. Analysis of his publication record reveals significant contributions to understanding myeloid neoplasms according to the International Consensus Classification and WHO 5th edition guidelines, hematologic alterations in viral respiratory infections, and therapeutic plasma exchange practices. His research bridges laboratory medicine with clinical applications, particularly in hematology and transfusion medicine. Kansas State Board of Healing Arts certification Dr. Chopra's scholarly work shows consistent contribution to pathology literature, with recent publications focusing on contemporary diagnostic challenges in hematopathology and the impact of viral pandemics on hematologic parameters. His collaborative approach is evident through numerous multi-institutional studies addressing critical questions in laboratory medicine and clinical pathology.

Scott AlterView profile

Associate Professor

• Emergency Medicine
• Geriatric Trauma
• Emergency Medical Services
• +4 more

Scott Alter, M.D., M.B.A. serves as Associate Professor of Emergency Medicine and Assistant Dean for Clinical Research at Florida Atlantic University's Charles E. Schmidt College of Medicine. He leads emergency medicine research initiatives and emergency medical services education while maintaining clinical practice as an emergency/hyperbaric physician at Bethesda Hospital East and Delray Medical Center. Dr. Alter holds dual board certification in emergency medicine and emergency medical services. Education: M.B.A. in Health Administration, Florida Atlantic University (2018) Emergency Medical Services Fellowship, Carolinas Medical Center (2013-2014) Emergency Medicine Residency, Morristown Medical Center (2010-2013) M.D., Rutgers Robert Wood Johnson Medical School (2010) B.S. in Communication Studies, University of Michigan (2004) Research Focus: Dr. Alter's work centers on geriatric emergency medicine, anticoagulation therapy in trauma patients, and emergency medical services education. His recent investigations focus on intracranial hemorrhage risk factors in elderly head trauma patients, anticoagulation management protocols, and innovative approaches to emergency medicine training. Publication Trends: Recent articles demonstrate a strong focus on geriatric head trauma outcomes, anticoagulation therapy complications, and medical education innovation. His research frequently incorporates clinical decision rules for imaging, pharmacogenomic interactions in elderly patients, and simulation-based training methodologies. Professional Recognition: Fellow of the American College of Emergency Physicians (FACEP) Fellow of the American Academy of Emergency Medicine (FAAEM) Clinical & Administrative Roles: As Research Director for the Emergency Medicine Residency, Dr. Alter oversees research infrastructure between FAU and hospital partners. He maintains active clinical practice while directing EMS education programs and serving as core residency faculty.

• Haematology
• Trauma Coagulopathy
• Endothelial Pathophysiology
• +3 more

Dr. Nicola Curry is an Associate Professor of Haematology and MRC Clinical Academic Research Partnership Fellow at the University of Oxford. She is also a Consultant Haematologist specializing in bleeding and clotting disorders, with a focus on inherited fibrinogen disorders and care for women with bleeding conditions. Her research explores endothelial regulation in trauma coagulopathy, aiming to improve treatments for major hemorrhage. She holds leadership roles in the UKHCDO Girls and Women with Bleeding Disorders Working Party, the ISTH SSC Fibrinogen and FXIII group, and the British Society for Haemostasis and Thrombosis. She trained in medicine at the University of Cambridge, completed clinical and haematology training in London and Oxford, and earned her MD under Prof. Simon Stanworth at NHS Blood & Transplant, Oxford. Her research interests include trauma coagulopathy pathophysiology, endothelial dysfunction, and thrombosis. Recent work focuses on machine learning in diagnostic imaging and clinical trials like the CRYOSTAT-2 study on cryoprecipitate use in trauma hemorrhage. Key publications address trauma management guidelines, thrombosis diagnostics, and transfusion strategies. She actively contributes to national and international committees shaping clinical practice and research. Her clinical practice integrates advanced haemostasis management with a focus on personalized care for complex bleeding disorders.